The PhysioMimix® benchtop 3D cell culture system from CN Bio has won the Innovation Award at the UK’s largest laboratory event, held at the NEC
CN Bio Innovations’ Board names David Hughes as next Chief Executive Officer
London, UK, 19 July 2018: CN Bio Innovations Limited today announced that its Board of Directors has accepted the resignation of Dr Emma Sceats as CEO
CN Bio launches PhysioMimix benchtop Human-Body-on-a-Chip device
London, UK, 23 May 2018: CN Bio Innovations Limited today launched PhysioMimix, a printer-sized device which allows scientist to conduct organ-on-chip
Radio 4’s PM features CN Bio Human Organ-on-Chips
Listen to Radio 4’s flagship PM programme with Caroline Quinn interview CN Bio Innovations’ CEO Dr Emma Sceats. Emma describes London-based CN Bio’s
CN Bio and MIT announce 10 Organ-On-chip platform: Nature Scientific Reports
Organ-on-Chip specialist CN Bio's microfluidic platform for improving drug evaluation has taken a significant step forward. CN Bio's partners at MIT
CN Bio MicroMix to be featured at AACR
Dr David Hughes, Chief Technical Officer at Organ-on-Chip specialist CN Bio Innovations will be presenting a poster at the American Association for
PharmaVentures interview: Will Organ-on-Chip technology provide the data regulators need in the future?
As new drug treatments are developed, quicker and much more precise technology which predicts the effect these chemical and biological substances have
Hepatitis B research using CN Bio Organ-on-chips published in Nature Communications
London, UK, February 15 2018: In an article published in Nature Communications scientists at Imperial College London have demonstrated how pathogens
R&D 100 Award won by Vanderbilt team for tech being developed with CN Bio
A cell-culture technology now being developed by London biotech CN Bio Innovations and its global pharmaceutical company partner, has won one of the